Cardiovascular Medicine
Page 1 • 3 itemsGlobal pharma market insights on cardiovascular medicine, including drug development, clinical trials, regulatory approvals, and M&A for investors.
Novo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection
Novo Nordisk's oral Ozempic pill receives FDA approval as the first oral GLP-1 medication for type 2 diabetes with cardiovascular risk reduction benefits.
InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial
InVera Medical's pilot trial shows 90% vein closure rates and significant quality of life improvements for chronic venous disease patients using its infusion device.
REVA Medical's MOTIV Sirolimus-Eluting Scaffold Shows Superior Results in Critical Limb Ischemia Trial
REVA Medical's MOTIV BTK trial met primary endpoint, showing sirolimus-eluting bioresorbable scaffold superiority in critical limb-threatening ischemia patients.